News

Show
news from

Autolus and Moderna sign Option and License Agreement for access to proprietary targeting technology from Autolus

Syncona Final Results for the Year Ended 31 March 2021

Autolus Therapeutics to report First Quarter 2021 Financial Results on May 6

Achilles Therapeutics announces pricing of initial public offering

Autolus announces proposed public offering in the United States

Autolus Therapeutics to report Fourth Quarter and Full Year 2020 financial results and host conference call on March 4

Load more

Search